GOOGL vs LLY: Which Is the Better Buy?
Side-by-side comparison of Alphabet Inc. and Eli Lilly and Company — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-09-26.
Alphabet Inc. · Communication Services
$342.36
+16.6% upside to fair value
Med Conviction
Grade B
High Quality
VS
Eli Lilly and Company · Healthcare
$1,183.72
+2.1% upside to fair value
Med Conviction
Grade B
High Quality
QuantHub Verdict
GOOGL has more upside to fair value
(+16.6%).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
GOOGL |
LLY |
| Current Price |
$342.36 |
$1,183.72 |
| Fair Value Estimate |
$399.26 |
$1,208.00 |
| Upside to Fair Value |
+16.6%
|
+2.1%
|
| Market Cap |
$4,143.3B |
$1,114.8B |
| Forward P/E |
—
|
—
|
| EV / EBITDA |
12.9x
|
26.8x
|
| Price / Sales |
9.3x
|
14.0x
|
| Price / FCF |
78.1x
|
52.7x
|
| Revenue Growth YoY |
+24.2%
|
+47.7%
|
| Gross Margin |
60.9%
|
83.4%
|
| Operating Margin |
33.1%
|
49.7%
|
| Return on Equity |
50.8%
|
92.6%
|
| Dividend Yield |
0.25% |
0.57% |
| FCF Yield |
1.28%
|
1.9%
|
| Analyst Consensus |
Strong Buy
|
Strong Buy
|
Investment Thesis
Alphabet is the parent of Google Services (Search, YouTube, Android, Chrome, hardware, and the Play store), Google Cloud, and Other Bets, and it remains one of the highest-quality large-cap franchises in the market, with a TTM gross margin of 60.9%, TTM operating margin of 33.1%, TTM net margin of 54.8%, and a 50.8% return on equity. Revenue growth in the most recent quarter was 24.2% year over y…
Eli Lilly is a global pharmaceutical company whose incretin franchise, led by Mounjaro and Zepbound, has become the dominant growth engine in diabetes and obesity care. The business quality is high: TTM gross margin is 83.4%, TTM operating margin is 49.7%, TTM net margin is 33.5%, and ROE is 92.6%, while revenue grew 47.7% and earnings grew 25.3% in the most recent quarter on a year-over-year bas…
Accumulation Zones
| Metric |
GOOGL |
LLY |
| Zone Low |
$299.44 |
$906.00 |
| Zone High |
$339.37 |
$1,026.80 |
| In Buy Zone? |
No
|
No
|